Epidermal growth factor alters silica nanoparticle uptake and improves gold-nanoparticle-mediated gene silencing in A549 cells

INTRODUCTION: Delivery of therapeutic nanoparticles (NPs) to cancer cells represents a promising approach for biomedical applications. A key challenge for nanotechnology translation from the bench to the bedside is the low amount of administered NPs dose that effectively enters target cells. To impr...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Nanotechnol
Auteurs principaux: Susnik, Eva, Bazzoni, Amelie, Taladriz-Blanco, Patricia, Balog, Sandor, Moreno-Echeverri, Aura Maria, Glaubitz, Christina, Oliveira, Beatriz Brito, Ferreira, Daniela, Baptista, Pedro Viana, Petri-Fink, Alke, Rothen-Rutishauser, Barbara
Format: Artigo
Langue:Inglês
Publié: 2023
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7615298/
https://ncbi.nlm.nih.gov/pubmed/37954478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnano.2023.1220514
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires